It is true that there are new drugs for new coronaviruses, such as ritonavir tablets and ambavizumab/romivizumab injection, but most are still in clinical trials, with REGN-COV2 and bamlanivimab currently approved for marketing in the United States. The March 15, 2022 National New Coronary Diagnostic Protocol includes ritonavir tablets and ambavizumab/romivizumab injection, two new coronary antiviral drugs, in antiviral therapy. New coronavirus pneumonia treatment drugs, the world is stepping up research and development. Small molecule drugs such as molnupiravir and Veklury and large molecule drugs such as lenzilumab and AZD7442 are being developed internationally. Currently, the drugs being developed in China are small molecule drugs such as ASC09/ritonavir, procurarumab, DC-402234 and neutralizing antibody-based large molecule drugs such as BRII-196/198, SCTA01, SCTA01 and so on. Tips] The “new coronavirus pneumonia, new coronavirus pneumonia” mentioned in this article has been renamed to “new coronavirus infection” on December 26, 2022, as announced by the National Health Commission.